Evidence map›Paper›PMID 41984913›Full record

ArticlePloS one2026

An algorithm to identify less invasive surfactant administration using a real-world database of preterm infants.

Xuezheng Sun, Annie N Simpson, Aditi Lahiri, Sanjida Mowla, Dana Edelman, Shelby Corman, Daniel Fuentes, Dalibor Kurepa, Michael W Kuzniewicz

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xuezheng SunChiesi USA Inc, Cary, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-2007-0802
Annie N SimpsonPrecision AQ, Bethesda, Maryland, United States of America.
Aditi LahiriDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America.
Sanjida MowlaChiesi USA Inc, Cary, North Carolina, United States of America.ORCID https://orcid.org/0000-0001-9305-9228
Dana EdelmanDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America.
Shelby CormanPrecision AQ, Bethesda, Maryland, United States of America.
Daniel FuentesChiesi USA Inc, Cary, North Carolina, United States of America.
Dalibor KurepaCincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America.
Michael W KuzniewiczDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America.ORCID https://orcid.org/0000-0002-3271-2999

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurfactant replacement therapy is central to respiratory distress syndrome (RDS) management in preterm infants, which can be delivered using a variety of methods. Less invasive surfactant administration (LISA) has been increasingly adopted due to its association with improved neonatal outcomes. However, there are no procedure codes to identify LISA in large real-world data (RWD), limiting the ability to evaluate its use and effectiveness on a large scale. This study aimed to develop an algorithm to identify LISA procedures using administrative data.

methodsWe conducted a retrospective study using chart reviews as the gold standard to identify preterm infants receiving surfactant via LISA or non-LISA procedures across Kaiser Permanente Northern California (KPNC) facilities. We selected 82 candidate variables from administrative data between birth and date of first surfactant administration. The algorithm was developed using births between 2019 and 2023, which were randomly split into a training set (n = 884) and testing set (n = 379). A least absolute shrinkage and selection operator (LASSO) regression was used for variable selection and model fitting. Model discrimination was evaluated using area under the receiver operating characteristic (AUROC). Algorithm performance was validated using a combined sample of the testing set and a 2024 birth cohort (n = 622) overall and by gestational age (GA) using sensitivity (Sn), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV).

resultsAmong 1,263 preterm infants who received surfactant, 462 (36.6%) received surfactant via LISA and 801 (63.4%) received surfactant via invasive modalities (ETT or INSURE). The LASSO-based model selected 21 variables predictive of LISA methods based on the training set. The model demonstrated strong discrimination (AUROC = 0.87). Using the maximum specificity cut-point (predicted probability ≥0.79), the model achieved Sn = 43.9%, Sp = 96.8%, PPV = 90.0% and NPV = 72.5%, with an overall agreement of 75.9% when evaluated in the combined testing set and 2024 birth cohort. Sn and Sp were consistent across GA subgroups.

conclusionsWe used a machine-learning approach to develop an algorithm that performed well in identifying surfactant administered via LISA among preterm infants using administrative data. The algorithm demonstrated strong performance and can support future research to evaluate the utilization and outcomes of LISA using RWD.

Indexed as

AlgorithmsPulmonary SurfactantsRespiratory Distress Syndrome, NewbornDatabases, FactualFemaleHumansInfant, NewbornInfant, PrematureMalePrediction AlgorithmsRetrospective StudiesPulmonary Surfactants

Identifiers

PMID41984913
PMCPMC13082626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.